iBio (IBIO)
Developing AI-enabled antibodies for obesity and body composition.
$1.32
Pre-market0.00 (0.00%)
At close$1.32(+4.76%)
Something off on this page? Send us feedback.
Next report
Nov 11, 2026
estimated · in 69 days
EPS estimate
−$0.07
Revenue estimate
$25.0K
Fiscal quarter
Q1 FY27
EPSReportedEstimate
Feb '25May '25Sep '25Nov '25Feb '26May '26Aug '26Nov '26
Reported−$0.48−$0.49−$0.31−$0.11−$0.09−$0.07−$0.04Pending
Estimate−$0.45−$0.39−$0.39−$0.07−$0.08−$0.06−$0.07−$0.07
Surprise−6.7%−25.6%+20.5%−57.1%−12.5%−16.7%+39.0%—
RevenueReportedEstimate
Feb '25May '25Sep '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$200.0K—$200.0K$100.0K———Pending
Estimate—$66.7K$100.0K$33.3K$50.0K$20.0K$80.0K$25.0K
Surprise——+100.0%+200.0%————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.07 | — | — |
| Aug 2026 | −$0.07 | −$0.04 | +39.0% |
| May 2026 | −$0.06 | −$0.07 | −16.7% |
| Feb 2026 | −$0.08 | −$0.09 | −12.5% |
| Nov 2025 | −$0.07 | −$0.11 | −57.1% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Sep 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Sep 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Sep 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Oct 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Sep 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Oct 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Sep 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Sep 2017 | |||
| May 2017 | |||
| Feb 2017 | |||
| Nov 2016 | |||
| Oct 2016 | |||
| May 2016 | |||
| Feb 2016 | |||
| Nov 2015 | |||
| Oct 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 11, 2026 | −$0.07 | — | — | $25.0K | — | — | — |
| Aug 28, 2026 | −$0.07 | −$0.04 | +39.0% | $80.0K | — | — | −2.9% |
| May 12, 2026 | −$0.06 | −$0.07 | −16.7% | $20.0K | — | — | −3.7% |
| Feb 10, 2026 | −$0.08 | −$0.09 | −12.5% | $50.0K | — | — | −2.6% |
| Nov 12, 2025 | −$0.07 | −$0.11 | −57.1% | $33.3K | $100.0K | +200.0% | −8.0% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||||||
| Sep 5, 2025 | |||||||
| May 2, 2025 | |||||||
| Feb 10, 2025 | |||||||
| Nov 12, 2024 | |||||||
| Sep 25, 2024 | |||||||
| May 13, 2024 | |||||||
| Feb 9, 2024 | |||||||
| Nov 14, 2023 | |||||||
| Sep 27, 2023 | |||||||
| May 11, 2023 | |||||||
| Feb 14, 2023 | |||||||
| Nov 14, 2022 | |||||||
| Oct 11, 2022 | |||||||
| May 12, 2022 | |||||||
| Feb 14, 2022 | |||||||
| Nov 15, 2021 | |||||||
| Sep 27, 2021 | |||||||
| May 17, 2021 | |||||||
| Feb 16, 2021 | |||||||
| Nov 16, 2020 | |||||||
| Oct 13, 2020 | |||||||
| May 15, 2020 | |||||||
| Feb 14, 2020 | |||||||
| Nov 14, 2019 | |||||||
| Aug 26, 2019 | |||||||
| May 10, 2019 | |||||||
| Feb 13, 2019 | |||||||
| Nov 13, 2018 | |||||||
| Sep 18, 2018 | |||||||
| May 11, 2018 | |||||||
| Feb 14, 2018 | |||||||
| Nov 9, 2017 | |||||||
| Sep 15, 2017 | |||||||
| May 15, 2017 | |||||||
| Feb 21, 2017 | |||||||
| Nov 18, 2016 | |||||||
| Oct 13, 2016 | |||||||
| May 23, 2016 | |||||||
| Feb 22, 2016 | |||||||
| Nov 13, 2015 | |||||||
| Oct 13, 2015 | |||||||